Filter
5858
Text search:
drug
information
Featured
Recommendations
528
New Publications
1543
Language
Document type
No document type
3477
Studies & Reports
882
Guidelines
754
Manuals
279
Strategic & Response Plan
181
Fact sheets
104
Training Material
87
Situation Updates
29
Resource Platforms
21
Brochures
19
Infographics
18
Online Courses
3
App
2
Videos
2
Countries / Regions
India
341
Global
199
Kenya
182
South Africa
145
Uganda
131
Ethiopia
128
Nigeria
116
Western and Central Europe
114
Tanzania
112
Nepal
108
Liberia
93
Malawi
92
Sierra Leone
91
Zambia
89
Myanmar / Burma
81
Africa
78
Ghana
77
Latin America and the Carribbean
76
Bangladesh
73
Rwanda
65
Namibia
59
Ukraine
55
Eastern Europe
52
Philippines
50
Zimbabwe
48
Asia
44
Cambodia
40
South–East Asia Region
40
Lesotho
35
Russia
31
Congo, Democratic Republic of
30
Botswana
30
Syria
27
Germany
24
Indonesia
24
Mozambique
23
Brazil
23
Senegal
22
Eswatini/ Swaziland
20
Haiti
18
South Sudan
18
East and Southern Africa
18
Middle East and North Africa
18
Burkina Faso
16
Eastern Europe and Central Asia
16
Cameroon
15
USA
14
Colombia
14
West and Central Africa
14
Thailand
13
Tajikistan
13
Guinea
12
Pakistan
12
Venezuela
12
China
11
Vietnam
11
Afghanistan
10
Albania
10
Georgia
10
Sudan
9
Benin
8
Laos
8
Sri Lanka
7
Yemen
7
Western Pacific Region
6
Moldova
6
Somalia
5
Iraq
5
Argentina
5
Peru
5
North Macedonia
5
Mexico
5
North America
5
Jordan
4
Lebanon
4
Turkey
4
Papua New Guinea
4
Central African Republic
4
El Salvador
4
Libya
4
Bhutan
4
Armenia
4
Timor Leste/ East Timor
4
Iran
4
Jamaica
4
United Kingdom
4
Mali
3
Switzerland
3
Bolivia
3
Paraguay
3
Fiji
3
Palestine
3
Uzbekistan
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Serbia
2
Hungary
2
Honduras
2
Angola
2
Madagascar
2
Chile
2
Poland
2
Mongolia
2
Southern Africa
2
Canada
2
Estonia
2
Kazakhstan
2
Gabon
2
France
2
Portugal
2
Guinea-Bissau
1
Saudi Arabia
1
Egypt
1
Chad
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Dominican Republic
1
Ecuador
1
Greece
1
Guatemala
1
Nicaragua
1
Solomon Islands
1
North Korea
1
Italy
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Australia
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2250
Clinical Guidelines
496
Public Health
274
Women & Child Health
224
Key Resources
161
Capacity Building
98
Pharmacy & Technologies
74
Annual Report MEDBOX
1
Toolboxes
HIV
700
Mental Health
592
TB
532
AMR
278
COVID-19
263
NTDs
237
Pharmacy
188
Caregiver
116
NCDs
115
Malaria
109
Refugee
87
Ebola & Marburg
86
Rapid Response
74
Planetary Health
71
Disability
66
Conflict
65
Global Health Education
58
Health Financing Toolbox
47
2.0 Rapid Response
29
Natural Hazards
24
Specific Hazards
22
Cholera
21
Polio
21
Zika
21
Social Ethics
14
This global guidance was developed to support malaria-free countries and those that are close to malaria elimination to prevent re-establishment. The document outlines key concepts and principles for preventing re-establishment and provides guidance on strategies, interventions, planning and managem
...
This policy brief presents a summary of current evidence on vulnerability to TB and proposes interventions for equitable, person-centred, and human rights-based TB prevention and care. It aligns with WHO policies and guidance on TB prevention and screening, management of TB and comorbidities, access
...
The National Malaria Elimination Strategic Plan (NMESP) 2024–2028 of Ghana outlines the country’s roadmap to shift from malaria control to elimination. Despite major progress—like reducing malaria deaths from nearly 2,800 in 2012 to 151 in 2022—malaria remains a major public health challenge
...
The Rwanda Malaria Strategic Plan 2020–2024 outlines Rwanda’s national strategy to reduce malaria morbidity and mortality by at least 50% compared to 2019 levels. The vision is a malaria-free Rwanda contributing to socioeconomic development.
The plan includes strengthening prevention through lo
...
National tuberculosis (TB) prevalence surveys provide a nationally representative measurement of the burden of TB disease in the population, at a given point in time. Repeat surveys allow assessment of trends and tracking of progress towards national and global targets for reductions in TB disease b
...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages
...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat
...
The 2024 edition reviews more than 50 health-related indicators from the Sustainable Development Goals and WHO’s Thirteenth General Programme of Work. It also highlights the findings from the Global health estimates 2021, notably the impact of the COVID-19 pandemic on life expectancy and healthy l
...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
Malaria remains a significant public health concern in the SADC region, accounting for 20% of childhood deaths, as well as prompting numerous outpatient visits and hospitalisations. Around three-quarters of the population, including 35 million children under the age of five and 8.5 million pregnant
...
Drawing on the World Health Organization’s package of NCD best buys, the report demonstrates how these evidence-based measures can help countries reduce premature deaths, strengthen health systems, and advance progress towards the Sustainable Development Goals. It provides policymakers, donors, ad
...
WHO guideline on HIV service delivery
recommended
Updated guidance on the integration of diabetes, hypertension and mental health services, and interventions to support adherence to antiretroviral therapy. The guideline offers practical implementation guidance for countries and key stakeholders as well as outlining key research gaps. As life expec
...
WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities, 2nd ed
recommended
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the latest WHO recommendations on TB and key comorbidities. The guidelines are a living document and will include dedicated sections for each key TB comorbidit
...
Current HIV/AIDS Reports (2022) 19:358–374. https://doi.org/10.1007/s11904-022-00615-z.
MINDSPACE is an acronym developed by the UK's behavioural insights team to summarise nine key influences on human behaviour: Messenger, Incentives, Norms, Default, Salience, Priming, Affect, Commitment, and E
...
AIDS 2024, 38:1579–1588. Treatment interruptions are a barrier to successful antiretroviral therapy (ART). 'Fresh start messages', which leverage significant days on the calendar (e.g., new year, public holiday) in order to prompt action, have the potential to encourage people with HIV (PWH) to re
...
Adolescents and young adults aged 10-24 remain underserved in the global response against HIV. Combination prevention, treatment and care programmes use a mix of evidence-based interventions to meet the current HIV prevention needs of adolescents and young adults. However, there needs to be a focus
...